These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29739878)

  • 1. BMPR2 inhibits activin and BMP signaling via wild-type ALK2.
    Olsen OE; Sankar M; Elsaadi S; Hella H; Buene G; Darvekar SR; Misund K; Katagiri T; Knaus P; Holien T
    J Cell Sci; 2018 Jun; 131(11):. PubMed ID: 29739878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.
    Olsen OE; Wader KF; Hella H; Mylin AK; Turesson I; Nesthus I; Waage A; Sundan A; Holien T
    Cell Commun Signal; 2015 Jun; 13():27. PubMed ID: 26047946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling.
    Xie C; Jiang W; Lacroix JJ; Luo Y; Hao J
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competition between type I activin and BMP receptors for binding to ACVR2A regulates signaling to distinct Smad pathways.
    Szilágyi SS; Amsalem-Zafran AR; Shapira KE; Ehrlich M; Henis YI
    BMC Biol; 2022 Feb; 20(1):50. PubMed ID: 35177083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activins bind and signal via bone morphogenetic protein receptor type II (BMPR2) in immortalized gonadotrope-like cells.
    Rejon CA; Hancock MA; Li YN; Thompson TB; Hébert TE; Bernard DJ
    Cell Signal; 2013 Dec; 25(12):2717-26. PubMed ID: 24018044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors.
    Olsen OE; Hella H; Elsaadi S; Jacobi C; Martinez-Hackert E; Holien T
    Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32235336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of BMPR2 leads to high bone mass due to increased osteoblast activity.
    Lowery JW; Intini G; Gamer L; Lotinun S; Salazar VS; Ote S; Cox K; Baron R; Rosen V
    J Cell Sci; 2015 Apr; 128(7):1308-15. PubMed ID: 25663702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alk2/ACVR1 and Alk3/BMPR1A Provide Essential Function for Bone Morphogenetic Protein-Induced Retinal Angiogenesis.
    Lee HW; Chong DC; Ola R; Dunworth WP; Meadows S; Ka J; Kaartinen VM; Qyang Y; Cleaver O; Bautch VL; Eichmann A; Jin SW
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):657-663. PubMed ID: 28232325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells.
    Quist-Løkken I; Andersson-Rusch C; Kastnes MH; Kolos JM; Jatzlau J; Hella H; Olsen OE; Sundan A; Knaus P; Hausch F; Holien T
    Cell Commun Signal; 2023 Jan; 21(1):25. PubMed ID: 36717825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
    Macías-Silva M; Hoodless PA; Tang SJ; Buchwald M; Wrana JL
    J Biol Chem; 1998 Oct; 273(40):25628-36. PubMed ID: 9748228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutively active ALK2 receptor mutants require type II receptor cooperation.
    Bagarova J; Vonner AJ; Armstrong KA; Börgermann J; Lai CS; Deng DY; Beppu H; Alfano I; Filippakopoulos P; Morrell NW; Bullock AN; Knaus P; Mishina Y; Yu PB
    Mol Cell Biol; 2013 Jun; 33(12):2413-24. PubMed ID: 23572558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor.
    Renlund N; O'Neill FH; Zhang L; Sidis Y; Teixeira J
    J Endocrinol; 2007 Oct; 195(1):95-103. PubMed ID: 17911401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activin A forms a non-signaling complex with ACVR1 and type II Activin/BMP receptors via its finger 2 tip loop.
    Aykul S; Corpina RA; Goebel EJ; Cunanan CJ; Dimitriou A; Kim HJ; Zhang Q; Rafique A; Leidich R; Wang X; McClain J; Jimenez J; Nannuru KC; Rothman NJ; Lees-Shepard JB; Martinez-Hackert E; Murphy AJ; Thompson TB; Economides AN; Idone V
    Elife; 2020 Jun; 9():. PubMed ID: 32515349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension.
    Shen H; Gao Y; Ge D; Tan M; Yin Q; Wei TW; He F; Lee TY; Li Z; Chen Y; Yang Q; Liu Z; Li X; Chen Z; Yang Y; Zhang Z; Thistlethwaite PA; Wang J; Malhotra A; Yuan JX; Shyy JY; Gong K
    Circulation; 2024 Jul; 150(2):132-150. PubMed ID: 38557054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK2 and BMPR2 knockdown and endothelin-1 production by pulmonary microvascular endothelial cells.
    Star GP; Giovinazzo M; Langleben D
    Microvasc Res; 2013 Jan; 85():46-53. PubMed ID: 23142694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type II BMP and activin receptors BMPR2 and ACVR2A share a conserved mode of growth factor recognition.
    Chu KY; Malik A; Thamilselvan V; Martinez-Hackert E
    J Biol Chem; 2022 Jul; 298(7):102076. PubMed ID: 35643319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Activation of the Fibrodysplasia Ossificans Progressiva-Inducing ALK2-R206H Mutant Depends on the Distinct Homo-Oligomerization Patterns of ACVR2B and ACVR2A.
    Szilágyi SS; Burdzinski W; Jatzlau J; Ehrlich M; Knaus P; Henis YI
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.
    Mitrofan CG; Appleby SL; Nash GB; Mallat Z; Chilvers ER; Upton PD; Morrell NW
    J Biol Chem; 2017 Aug; 292(33):13714-13726. PubMed ID: 28646109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
    Yu PB; Beppu H; Kawai N; Li E; Bloch KD
    J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.